See Asa at Microbiome & Probiotic R&D & Business Collaboration Forum - La Jolla, California 10/13/2025
February 9, 2022 By: Asa Waldstein

Learning targets: Children, risky words, intranasal, ingredient benefits

Takeaway -

Use caution copy & pasting “ingredient benefits” onto commercial website

Warning Letter Wednesday is a cautionary tale for companies new to the space that are looking to market products.

This company looks like a groovy crystal shop that started making topical products and products delivered to the eyes and nose.

So what can we learn?

Of course, there are high risks words referenced in the warning letter, Notably, the use of viruses, cancer, and so many more!

Products delivered through the nose (intranasal) or as an eye drop are drugs and have a justifiable higher level of scrutiny.

Products marketed for use by children are high-risk.

This warning letter is a good teaching tool. Copying and pasting a product’s “therapeutic uses” from a textbook or website is a great way to get into trouble. This appears to be the case here.

From warning letter: Colloidal silver is used to treat infections due to yeast; bacteria (tuberculosis, Lyme disease, bubonic plague, pneumonia, leprosy, gonorrhea, syphilis, scarlet fever, stomach ulcers, cholera); parasites (ringworm, malaria); and viruses (HIV/AIDS, pneumonia, herpes, shingles, warts).

Asa comments: I understand these are obvious high-risk claims, but in some ways, this could have happened to any entrepreneur that doesn’t understand the rules of marketing products. I have seen this happen several times with practitioners, herbalists, and even doctors that “cross the line” into marketing claims by using common therapeutic language such as anti-inflammatory and even “clears heat and resolves toxins.” We talk about this here

From warning letter: “…. to heal skin irritations and scarring.”

Asa comments: Interestingly, there are a couple of references to helping skin irritations and scarring. I do not consider these to be high risk. They are likely a “pig pile” or a common secondary claim in warning letters. What are your thoughts on the risk level here?

Read the warning letter here.

In closing, I think the FDA would have left this company alone if there were not talking about viruses, selling products that go into the nose and eyes, are marketed as safe for children, and had just too many disease words to be avoided.

I started a LinkedIn group just for warning letter discussion. Join here.

Disclaimer: The educational information provided here is for informational purposes only. Contact an attorney for specific legal advice. Rule #1 in compliance is to ensure marketing is truthful and not misleading.

Written by

Asa Waldstein
Asa Waldstein
Asa Waldstein is a 24-year veteran of the dietary supplement industry, with experience spanning manufacturing, marketing, and regulatory compliance. He is the principal of Apex Compliance, a software company dedicated to streamlining regulatory marketing compliance for the dietary supplement and natural products sectors. Asa also leads Supplement Advisory Group, a boutique consultancy focused on marketing risk analysis, labeling, and practical compliance strategies for websites and social media. Asa has helped oversee three FDA GMP inspections with no 483s and was honored with the 2023 AHPA Herbal Hero Award and the 2024 What's Up Supps Policy and Change Agent Award. He currently serves as Chair of the American Herbal Products Association’s (AHPA) Cannabis Committee, helping shape policy and industry best practices